SlideShare a Scribd company logo
SUBARACHNOID
HEMORRHAGE
Dr. Ashish Chowdhury
Resident (Neurology), Phase B,BSMMU
Introduction
Bleeding into the subarachnoid space (space between the pia &
arachnoid meningeal layers where blood vessels lie & CSF
flows.)
Introduction
 Less common than other types of stroke only 5%
 Affects about 6/100000 population
 Women more common
 Usually presents before 65 yrs
 Most commonly occurs between 40- 60 yrs
Immediate mortality : about 30%
Recurrence: 40% in first 4 weeks, 3% annually
Risk factors
Head injury
Hypertension
Female gender
Alcohol abuse
Cocaine abuse
Family history
Connective tissue disease
PKD
Fibromuscular dysplasia
Causes of Non Traumatic SAH
• Ruptured berry aneurysm 85%
• Non aneurysmal or perimesencephalic haemorrhage-10%
• Rupture AVM
• Vertebral Artery Dissection
Aneurysm
• About 2% of adults harbor intracranial aneurysm.
• Ruptured, Unruptured
• Saccular,Mycotic,Fusiform,globular,Gaint,Diffuse
• Most common locations are-
Anterior Circulation
Terminal ICA
Bifurcation of MCA
Top of the Basilar artery
Aneurysm
• Size- 2mm to 3cm
• Average size- 7.5mm
• Those which rupture are usually 10mm or more but smaller ones can
also get ruptured
Common sites of aneurysm
What causes the aneurysms to form?
• Defects in the media of the arteries
• Defects are thought to expand as a result of hydrostatic pressure from
pulsatile blood flow and blood turbulence, which is greatest at the
arterial bifurcations
• Other theory says it is initiated by focal destruction of internal elastic
membrane caused by hemodynamic forced acting at bifurcations &
branching of arteries. As a result of local weakness in vessel wall
intima bulges out covered only by adventetia
Clinical Feature
Sudden severe thunderclap headache
Often occipital
Last for hours or even days
Vomiting
Antecedents –
Physical exertion
Straining
Sexual excitement
Loss of conciousness at onset
Distressed
Irritable
Photophobia
Signs of meningeal irritation
Seizure
Focal sign – If intracerebral haematoma
Hemiparesis
Aphasia
3rd CN palsy – Pcom
3rd 4th 6th CN palsy-Cavernous sinus
Fundus -
Subhyaloid hge,Papilloedema
Investigations
• To diagnose SAH
- High resolution non-contrast CT head
- Lumbar puncture & CSF study
- MRI brain
• To identify the source
- CT angiography
- MR angiography
- DSA
Investigations contd..
• Others:
• Complete blood count
• S. electrolytes, ABG: hyponatremia
• PT, APTT: coagulopathy
• Cardiac enzymes, ECG
• High resolution non-contrast CT detect SAH in almost 95% cases in
first 3 days
• Blood appears high density in subarachnoid space
• After 5-7 days sensitivity decreases sharply
• Also assesses ventricular size, infarct, hemorrhage
• May predict aneurysm location based on pattern of blood
• Anterior interhemispheric fissure- Acom
• One sylvian fissure- Ipsilateral MCA or Pcom
• Prepontine or peduncular cistern- Basilar top or SCA
CT Scan
CT Scan
Basilar tip aneurysm
rupture
Unenhanced CT brain
showing blood in basal
cisterns & mild hydrocephalus
CT Scan contd..
Fisher grading for SAH on CT:
• Grade 1 - No subarachnoid blood seen on CT scan
• Grade 2 - Diffuse or vertical layers of SAH less than 1 mm thick
• Grade 3 - Diffuse clot and/or vertical layer greater than 1 mm
thick
• Grade 4 - Intracerebral or intraventricular clot with diffuse or no
subarachnoid blood
Lumbar Puncture
• Usually done when CT is negative but strong clinical suspicion
• Opening pressure: elevated
• Non-clotting bloody fluids not clearing with sequential tubes
• Xanthochromia
• Yellowish coloration of CSF supernatent
• Almost 100% sensitive after 12 hours, 40% at 4 weeks
• Spectrophotometry is more sensitive than visual inspection
• False negative: Jaundice, very high CSF protein
CSF color in SAH
MRI
• Not sensitive in first 24-48 hours due to less methemoglobin
• Better after 4-7 days for subacute hemorrhage
• FLAIR & proton density images may be as sensitive as CT in acute
stage
• FLAIR, DWI, GRE, proton density sequences may help diagnosis in the
second week when CT are being negative
A. GRE MRI after 10 days of SAH shows blood in left Sylvian fissure
B. DSA shows a small aneurysm in left MCA bifurcation
Angiophraphy
• CTA may detect aneurysm in 97% cases
• MRA is 92% sensitive, 97% specific
• For decision of type of repair, DSA is indicated
• Sensitivity is less for aneurysm less than 3mm size
• 10-15% SAH are angio-negative (perimesencephalic SAH)
• Repeat angiogram may be needed 2-3 weeks later
Basilar tip aneurysm: before & after coiling
Diagnostic algorithm for SAH
Treatment
Historical concept:
• Strict BP control
• Fluid restriction
• Conservative approach & delay in specific management
This approach was associated with high mortality & morbidity due to
complications of hypovolemia, hypotension & rebleeding
Treatment
• Initial stabilization & monitoring
• Endovascular coiling or Surgical clipping
• Prevention & treatment of complications
Treatment contd..
• Pt should be admitted in Neuro-ICU
• Initial stabilization: Assess airway, breathing, circulation
• Endotracheal intubation is indicated if the pt is in coma, depressed
consciousness or unable to protect airway
• Monitoring:
• Cardiac monitoring
• Pulse oximetry
• Arterial BP monitoring
• Urine output via catheter
• The focus in the first few minutes to hours after SAH, until the patient
can undergo treatment of the ruptured aneurysm, should be directed
toward the prevention of rebleeding.
• This life-threatening complication, with a mortality rate of 20% to 60%,
has its highest rate (8%to 23%) within the first 72 hours after SAH, with
the majority of rebleeding (50% to 90%) occurring within the first 6
hours
HUNT AND HESS SCALE
Grade 0: Asymptomatic
Grade 1: Mild headache and mild nuchal rigidity, no neurological
deficit
Grade 2: Moderate to severe headache but no neurological deficit
other than cranial nerve palsy
Grade 3: Drowsy, confused, or mild focal deficit
Grade 4: Stupor, moderate to severe hemiparesis, and early
decerebrate posturing
Grade 5: Deep comatose, decerebrate posturing
WORLD FEDERATION OF NEUROLOGICAL SURGEONS
(WFNS) SCALE
Glasgow coma scale Motor deficit
Grade 0 15 Absent
Grade 1 15 Present
Grade 2 13–14 Absent
Grade 3 13–14 Present
Grade 4 7–12 Present or absent
Grade 5 3–6 Present or absent
Blood Pressure Management
• Early management is important to prevent rebleeding & to maintain
cerebral perfusion pressure
• Start antihypertensive agent if SBP>160 or MBP>130 mmHg
• Target BP: SBP no more than 140 mmHg unless vasospasm
• i.v. beta blocker labetalol, if no contra-indication, is the first choice
because it has short half-life, is easily titratable & do not raise ICP
• Nitroglycerine & nitroprusside raise ICP
• ACE inhibitors are delayed acting
Treatment of aneurysm
• With the publication of the ISAT, the treatment of an unsecured aneurysm has
shifted from surgical clipping to mostly endovascular coiling.
• ISAT showed that patients in the endovascular coiling group had significantly
higher odds of survival free of disability 1 year after SAH and a lower risk of
epilepsy when compared to the surgical clipping group.
• Even 10 years after SAH, patients who underwent endovascular coiling had better
outcome.
Coiling &
Clipping
Coiling vs Clipping
Endovascular & Surgical Treatment
• Should be performed as early as possible in low to intermediate grade
SAH (HHS or WFNS grade 1-3)
• Severe grade pts may be candidate for delayed coiling or clipping
• Endovascular coiling is preferred due to less complication
• Follow-up vascular imaging is indicated
• Retreatment should be considered by repeat coiling or clipping if
there is clinically significant remnant
Coiling vs Clipping
Endovascular treatment is favored over open surgery in the
following situations:
• Aneurysms in the posterior circulation because of the high surgical
morbidity
• Patients with higher-grade SAH (i.e. Hunt and Hess/WFNS grades 4-5)
• Patients who are medically unstable
• Patients with symptomatic cavernous aneurysms
• Patients with vasospasm
• Patients in whom the aneurysm lacks a defined surgical neck
• Patients with multiple aneurysms in different arterial territories if the
surgical risk is high
Coiling vs Clipping contd..
Clipping is favored in cases of:
• Mass effect or large hematoma (>50 ml) associated with aneurysm
• Large and giant aneurysm
• MCA aneurysm
• Wide-necked aneurysms - A large neck-to-dome ratio makes acute
endovascular coiling of wide-necked aneurysms more difficult
• Recurrent aneurysm after coil embolization
Complications of Coiling
• Aneurysm rupture
• Thromboembolism with acute or delayed neurologic deficit
(stroke)
• Coil displacement or compaction
• Nonspecific access complications such as groin hematoma or
arterial dissection
Management of neurological complications
• Rebleeding
• Hydrocephalus
• Seizure
• Delayed Cerebral Ischemia (DCI)
Rebleeding
• Most dangerous complication
• Risk is 60% in first 24 hour, 20 % at 14 days
• Risk factors:
• Large aneurysm
• Poorly controlled BP
• Higher Hunt & Hess grade
• Delay in coiling or clipping
• Use of antiplatelet
Rebleeding contd…
Rebleeding contd..
Prevention:
• Bed rest in a quiet room
• Analgesia, preferably with short acting agent e.g. fentanyl
• Sedation, preferably with short acting agent e.g. midazolam
• Stool softener
• Management of BP
• Early coiling or clipping
• Antifibrinolytics reduce risk of rebleeding but increase risk of
infarction: may be given for short term (<72 hours)
Vasospasm & Cerebral Ischemia
• Occur 7-10 days after SAH & resolves spontaneously after 21 days
• Amount of blood on initial CT is a good predictor
• Hypovolemia & hypotension may precipitate vasospasm
• Presents with new focal neurological deficit or global symptom
• Prevention:
• Avoid hypotension
• Maintain euvolemia
• oral nimodipine for 21 days- (60 mg every 4 hours for 21 days)
• Monitoring: daily bedside transcranial Doppler USG
Vasospasm contd…
Vasospasm & Cerebral Ischemia contd..
Treatment of symptomatic vasospasm:
• Triple H therapy:
• Hypertension
• Hypervolemia
• Hemodilution. If bleeding site is not secured before, rebleeding may occur
• Transluminal balloon angioplasty
• Intra-arterial vasodilator therapy e.g. CCB, papaverine, Mg
Acute Hydrocephalus
• Usually within first 24 hours
• Occurs in 20% cases
• Obstructive type
• Blood in ventricles in initial CT is a good predictor
• Presents with sudden neurologic deterioration
• CT may differentiate from rebleeding
• In obtunded pt, emergency ventriculostomy is needed
Chronic Hydrocephalus
• After 10 days
• 10-15% cases
• Communicating type
• Presents with, incontinence, ataxia, cognitive impairment
• May be difficult to distinguish from vasospasm
• Permanent CSF diversion (Shunt) may be needed
Seizure
• Occur in 26% cases
• Risk factors include hematoma, infarct, MCA aneurysm
• Short term prophylaxis may be considered in high risk pts
• Long term prophylaxis not recommended
• Phenytoin, Levetiracetam is the agent of choice
• Phenytoin i.v. can achieve rapid therapeutic concentration and it does
not cause alteration in consciousness
• Phenobarbital produces a sedative effect, which may mask the
neurologic evaluation
Medical complications
• Cardiorespiratory Dysfunction
• Fever
• Hyponatremia
• Thromboembolism & prophylaxis
• Glycemic Dysfunction
Hyponatremia
• Occur in 10-30% cases
• Cerebral salt wasting occur due to excess BNP
• SIADH may also occur
• CSW is hypovolemic, SIADH is euvolemic
• Isotonic saline prevents hypovolemia, but not hyponatremia for
which hypertonic saline may be needed
Cardiopulmonary dysfunction
• Ranges from minor ECG changes to severe stress cardiomyopathy and
neurogenic pulmonary edema.
• The severity of SAH is an independent predictor of cardiopulmonary injury,
• The cardiopulmonary injury is neurally mediated.
• Cardiopulmonary complications after SAH are usually transient and resolve
within several days to 2 weeks.
• Fever
- most common medical complication( up to 70% of patients)
- searching for infection & antipyretic
• Glycemic Dysfunction:
-current recommendations are to maintain a
blood glucose level between 80 mg/dL and
200 mg/dL.
Deep vein thrombosis
prophylaxis
• All pt should have pneumatic compression stocking
• UH can be used within 1-2 days following aneurysms treatment
• IVC filter if DVT or PE occurs after clipping
• Systemic anticoagulation if DVT or PE occurs after coiling..
Reference
• CONTINUUM (MINNEAP MINN) 2018;24(6, NEUROCRITICAL CARE):
1623–1657.
• Harrison's Principles of Internal Medicine, Twentieth Edition.
• Adams and Victor's Principles of Neurology 11th Edition
THANK YOU

More Related Content

What's hot

Sub-arachnoid hemorrhage
Sub-arachnoid hemorrhageSub-arachnoid hemorrhage
Sub-arachnoid hemorrhage
Maulik Panchal
 
Normal pressure hydrocephalus
Normal pressure hydrocephalusNormal pressure hydrocephalus
Normal pressure hydrocephalus
NeurologyKota
 
Tuberous sclerosis
Tuberous sclerosis Tuberous sclerosis
Tuberous sclerosis
Siva Pesala
 
Transcranial doppler
Transcranial dopplerTranscranial doppler
Transcranial doppler
Dr Himanshu Soni
 
CEREBRAL VENOUS THROMBOSIS
CEREBRAL VENOUS THROMBOSISCEREBRAL VENOUS THROMBOSIS
CEREBRAL VENOUS THROMBOSIS
Divakar Reddy
 
Nmosd & mog
Nmosd & mogNmosd & mog
Nmosd & mog
NeurologyKota
 
Wheat pill poisoning presentation
Wheat pill poisoning presentationWheat pill poisoning presentation
Wheat pill poisoning presentation
Arsalan Masoud
 
Moyamoya disease
Moyamoya diseaseMoyamoya disease
Moyamoya disease
Ayman Al-Malt
 
neuromyelitis optica spectrum disorder Dr. Musa Atarzadeh
neuromyelitis optica spectrum disorder   Dr. Musa Atarzadehneuromyelitis optica spectrum disorder   Dr. Musa Atarzadeh
neuromyelitis optica spectrum disorder Dr. Musa Atarzadeh
Musa Atazadeh
 
Idiopathic Intracranial Hypertension
Idiopathic Intracranial HypertensionIdiopathic Intracranial Hypertension
Idiopathic Intracranial Hypertension
Srirama Anjaneyulu
 
SAH (Subarachnoid Haemorrhage)
SAH (Subarachnoid Haemorrhage)SAH (Subarachnoid Haemorrhage)
SAH (Subarachnoid Haemorrhage)
Jigar Padalia
 
Approach to demyelinating diseases
Approach to demyelinating diseasesApproach to demyelinating diseases
Approach to demyelinating diseases
NeurologyKota
 
Posterior reversible encephalopathy syndrome
Posterior reversible encephalopathy syndromePosterior reversible encephalopathy syndrome
Posterior reversible encephalopathy syndrome
NeurologyKota
 
Nph
NphNph
Moyamoya Angiopathy
Moyamoya AngiopathyMoyamoya Angiopathy
Moyamoya Angiopathy
Ade Wijaya
 
SUBARACHNOID HEMORRHAGE
SUBARACHNOID HEMORRHAGESUBARACHNOID HEMORRHAGE
SUBARACHNOID HEMORRHAGE
HIRANGER
 
SAH for Neurology Residents
SAH for Neurology ResidentsSAH for Neurology Residents
SAH for Neurology Residents
Dhaval Shukla
 
TIA and stroke prevention
TIA and stroke preventionTIA and stroke prevention
TIA and stroke prevention
Lobna A.Mohamed
 
Acute Stroke management
Acute Stroke managementAcute Stroke management
Acute Stroke management
Javed Ahamed
 
Presentation1 pseudotumor
Presentation1 pseudotumorPresentation1 pseudotumor
Presentation1 pseudotumor
Drgeeta Choudhary
 

What's hot (20)

Sub-arachnoid hemorrhage
Sub-arachnoid hemorrhageSub-arachnoid hemorrhage
Sub-arachnoid hemorrhage
 
Normal pressure hydrocephalus
Normal pressure hydrocephalusNormal pressure hydrocephalus
Normal pressure hydrocephalus
 
Tuberous sclerosis
Tuberous sclerosis Tuberous sclerosis
Tuberous sclerosis
 
Transcranial doppler
Transcranial dopplerTranscranial doppler
Transcranial doppler
 
CEREBRAL VENOUS THROMBOSIS
CEREBRAL VENOUS THROMBOSISCEREBRAL VENOUS THROMBOSIS
CEREBRAL VENOUS THROMBOSIS
 
Nmosd & mog
Nmosd & mogNmosd & mog
Nmosd & mog
 
Wheat pill poisoning presentation
Wheat pill poisoning presentationWheat pill poisoning presentation
Wheat pill poisoning presentation
 
Moyamoya disease
Moyamoya diseaseMoyamoya disease
Moyamoya disease
 
neuromyelitis optica spectrum disorder Dr. Musa Atarzadeh
neuromyelitis optica spectrum disorder   Dr. Musa Atarzadehneuromyelitis optica spectrum disorder   Dr. Musa Atarzadeh
neuromyelitis optica spectrum disorder Dr. Musa Atarzadeh
 
Idiopathic Intracranial Hypertension
Idiopathic Intracranial HypertensionIdiopathic Intracranial Hypertension
Idiopathic Intracranial Hypertension
 
SAH (Subarachnoid Haemorrhage)
SAH (Subarachnoid Haemorrhage)SAH (Subarachnoid Haemorrhage)
SAH (Subarachnoid Haemorrhage)
 
Approach to demyelinating diseases
Approach to demyelinating diseasesApproach to demyelinating diseases
Approach to demyelinating diseases
 
Posterior reversible encephalopathy syndrome
Posterior reversible encephalopathy syndromePosterior reversible encephalopathy syndrome
Posterior reversible encephalopathy syndrome
 
Nph
NphNph
Nph
 
Moyamoya Angiopathy
Moyamoya AngiopathyMoyamoya Angiopathy
Moyamoya Angiopathy
 
SUBARACHNOID HEMORRHAGE
SUBARACHNOID HEMORRHAGESUBARACHNOID HEMORRHAGE
SUBARACHNOID HEMORRHAGE
 
SAH for Neurology Residents
SAH for Neurology ResidentsSAH for Neurology Residents
SAH for Neurology Residents
 
TIA and stroke prevention
TIA and stroke preventionTIA and stroke prevention
TIA and stroke prevention
 
Acute Stroke management
Acute Stroke managementAcute Stroke management
Acute Stroke management
 
Presentation1 pseudotumor
Presentation1 pseudotumorPresentation1 pseudotumor
Presentation1 pseudotumor
 

Similar to Subarachnoid Haemorrhage Management

SUBARACHNOID HEMORRHAGE
SUBARACHNOID HEMORRHAGESUBARACHNOID HEMORRHAGE
SUBARACHNOID HEMORRHAGE
AbhinovKandur
 
sub arachnoid hemorrhage
sub arachnoid hemorrhage sub arachnoid hemorrhage
sub arachnoid hemorrhage
Shambhavi Sharma
 
Non traumatic Subarachnoid hemorrhage (SAH)
Non traumatic Subarachnoid hemorrhage (SAH)Non traumatic Subarachnoid hemorrhage (SAH)
Non traumatic Subarachnoid hemorrhage (SAH)
Milan Silwal
 
Diagnosing Subarachnoid Haemorrhage in Neuro Critical Care
Diagnosing Subarachnoid Haemorrhage in Neuro Critical CareDiagnosing Subarachnoid Haemorrhage in Neuro Critical Care
Diagnosing Subarachnoid Haemorrhage in Neuro Critical Care
SMACC Conference
 
Anesthesia for cerebral aneurysm repair
Anesthesia for cerebral aneurysm repairAnesthesia for cerebral aneurysm repair
Anesthesia for cerebral aneurysm repair
Dhritiman Chakrabarti
 
Stroke-and-Spinal-Cord-7-30.ppt
Stroke-and-Spinal-Cord-7-30.pptStroke-and-Spinal-Cord-7-30.ppt
Stroke-and-Spinal-Cord-7-30.ppt
Ankur Jain
 
subarachnoid hemorrhage
subarachnoid hemorrhagesubarachnoid hemorrhage
subarachnoid hemorrhage
Abdul Waris
 
Subarachnoid haemorrhage
Subarachnoid haemorrhage Subarachnoid haemorrhage
Subarachnoid haemorrhage
NITAYSBMC
 
CeAD.pptx
CeAD.pptxCeAD.pptx
CeAD.pptx
DrMudasirMushtaq
 
SUBARACHNOID HEMORRHAGE
SUBARACHNOID HEMORRHAGESUBARACHNOID HEMORRHAGE
SUBARACHNOID HEMORRHAGE
DR. JITHIN GEORGE
 
Aneurysms neurosurgery of CNS12341234.pptx
Aneurysms neurosurgery of CNS12341234.pptxAneurysms neurosurgery of CNS12341234.pptx
Aneurysms neurosurgery of CNS12341234.pptx
RanveerKumarVerma
 
Subarachnoid hemorrhage in brain. .pptx
Subarachnoid hemorrhage in brain.   .pptxSubarachnoid hemorrhage in brain.   .pptx
Subarachnoid hemorrhage in brain. .pptx
Abhi906519
 
Ischemic Stroke investigations
Ischemic Stroke investigations Ischemic Stroke investigations
Ischemic Stroke investigations
Ashish Chowdhury
 
Cerebrovascular diseases 2.pptx
Cerebrovascular diseases 2.pptxCerebrovascular diseases 2.pptx
Cerebrovascular diseases 2.pptx
SuzanM1
 
Sah
SahSah
Χειρουργική αντιμετώπιση ανευρυσμάτων εγκεφάλου.
Χειρουργική αντιμετώπιση ανευρυσμάτων εγκεφάλου.Χειρουργική αντιμετώπιση ανευρυσμάτων εγκεφάλου.
Χειρουργική αντιμετώπιση ανευρυσμάτων εγκεφάλου.
Κωνσταντίνος Δαβανέλος
 
SAH.pptx
SAH.pptxSAH.pptx
SAH.pptx
Mohit435071
 
Aneurysm surgery.pptx
Aneurysm surgery.pptxAneurysm surgery.pptx
Aneurysm surgery.pptx
JunayedMahmud1
 
Sub arachanoid heamorrhage
Sub arachanoid heamorrhageSub arachanoid heamorrhage
Sub arachanoid heamorrhage
alyaqdhan
 
I LOVE NEUROSURGERY INITIATIVE: Subarachnoid Hemorrhage
I LOVE NEUROSURGERY INITIATIVE: Subarachnoid HemorrhageI LOVE NEUROSURGERY INITIATIVE: Subarachnoid Hemorrhage
I LOVE NEUROSURGERY INITIATIVE: Subarachnoid Hemorrhage
walid maani
 

Similar to Subarachnoid Haemorrhage Management (20)

SUBARACHNOID HEMORRHAGE
SUBARACHNOID HEMORRHAGESUBARACHNOID HEMORRHAGE
SUBARACHNOID HEMORRHAGE
 
sub arachnoid hemorrhage
sub arachnoid hemorrhage sub arachnoid hemorrhage
sub arachnoid hemorrhage
 
Non traumatic Subarachnoid hemorrhage (SAH)
Non traumatic Subarachnoid hemorrhage (SAH)Non traumatic Subarachnoid hemorrhage (SAH)
Non traumatic Subarachnoid hemorrhage (SAH)
 
Diagnosing Subarachnoid Haemorrhage in Neuro Critical Care
Diagnosing Subarachnoid Haemorrhage in Neuro Critical CareDiagnosing Subarachnoid Haemorrhage in Neuro Critical Care
Diagnosing Subarachnoid Haemorrhage in Neuro Critical Care
 
Anesthesia for cerebral aneurysm repair
Anesthesia for cerebral aneurysm repairAnesthesia for cerebral aneurysm repair
Anesthesia for cerebral aneurysm repair
 
Stroke-and-Spinal-Cord-7-30.ppt
Stroke-and-Spinal-Cord-7-30.pptStroke-and-Spinal-Cord-7-30.ppt
Stroke-and-Spinal-Cord-7-30.ppt
 
subarachnoid hemorrhage
subarachnoid hemorrhagesubarachnoid hemorrhage
subarachnoid hemorrhage
 
Subarachnoid haemorrhage
Subarachnoid haemorrhage Subarachnoid haemorrhage
Subarachnoid haemorrhage
 
CeAD.pptx
CeAD.pptxCeAD.pptx
CeAD.pptx
 
SUBARACHNOID HEMORRHAGE
SUBARACHNOID HEMORRHAGESUBARACHNOID HEMORRHAGE
SUBARACHNOID HEMORRHAGE
 
Aneurysms neurosurgery of CNS12341234.pptx
Aneurysms neurosurgery of CNS12341234.pptxAneurysms neurosurgery of CNS12341234.pptx
Aneurysms neurosurgery of CNS12341234.pptx
 
Subarachnoid hemorrhage in brain. .pptx
Subarachnoid hemorrhage in brain.   .pptxSubarachnoid hemorrhage in brain.   .pptx
Subarachnoid hemorrhage in brain. .pptx
 
Ischemic Stroke investigations
Ischemic Stroke investigations Ischemic Stroke investigations
Ischemic Stroke investigations
 
Cerebrovascular diseases 2.pptx
Cerebrovascular diseases 2.pptxCerebrovascular diseases 2.pptx
Cerebrovascular diseases 2.pptx
 
Sah
SahSah
Sah
 
Χειρουργική αντιμετώπιση ανευρυσμάτων εγκεφάλου.
Χειρουργική αντιμετώπιση ανευρυσμάτων εγκεφάλου.Χειρουργική αντιμετώπιση ανευρυσμάτων εγκεφάλου.
Χειρουργική αντιμετώπιση ανευρυσμάτων εγκεφάλου.
 
SAH.pptx
SAH.pptxSAH.pptx
SAH.pptx
 
Aneurysm surgery.pptx
Aneurysm surgery.pptxAneurysm surgery.pptx
Aneurysm surgery.pptx
 
Sub arachanoid heamorrhage
Sub arachanoid heamorrhageSub arachanoid heamorrhage
Sub arachanoid heamorrhage
 
I LOVE NEUROSURGERY INITIATIVE: Subarachnoid Hemorrhage
I LOVE NEUROSURGERY INITIATIVE: Subarachnoid HemorrhageI LOVE NEUROSURGERY INITIATIVE: Subarachnoid Hemorrhage
I LOVE NEUROSURGERY INITIATIVE: Subarachnoid Hemorrhage
 

Recently uploaded

Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Swastik Ayurveda
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
70KRISHPATEL
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
rightmanforbloodline
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 

Recently uploaded (20)

Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 

Subarachnoid Haemorrhage Management

  • 2. Introduction Bleeding into the subarachnoid space (space between the pia & arachnoid meningeal layers where blood vessels lie & CSF flows.)
  • 3. Introduction  Less common than other types of stroke only 5%  Affects about 6/100000 population  Women more common  Usually presents before 65 yrs  Most commonly occurs between 40- 60 yrs
  • 4. Immediate mortality : about 30% Recurrence: 40% in first 4 weeks, 3% annually
  • 5. Risk factors Head injury Hypertension Female gender Alcohol abuse Cocaine abuse Family history Connective tissue disease PKD Fibromuscular dysplasia
  • 6. Causes of Non Traumatic SAH • Ruptured berry aneurysm 85% • Non aneurysmal or perimesencephalic haemorrhage-10% • Rupture AVM • Vertebral Artery Dissection
  • 7. Aneurysm • About 2% of adults harbor intracranial aneurysm. • Ruptured, Unruptured • Saccular,Mycotic,Fusiform,globular,Gaint,Diffuse • Most common locations are- Anterior Circulation Terminal ICA Bifurcation of MCA Top of the Basilar artery
  • 8. Aneurysm • Size- 2mm to 3cm • Average size- 7.5mm • Those which rupture are usually 10mm or more but smaller ones can also get ruptured
  • 9. Common sites of aneurysm
  • 10. What causes the aneurysms to form? • Defects in the media of the arteries • Defects are thought to expand as a result of hydrostatic pressure from pulsatile blood flow and blood turbulence, which is greatest at the arterial bifurcations • Other theory says it is initiated by focal destruction of internal elastic membrane caused by hemodynamic forced acting at bifurcations & branching of arteries. As a result of local weakness in vessel wall intima bulges out covered only by adventetia
  • 11. Clinical Feature Sudden severe thunderclap headache Often occipital Last for hours or even days Vomiting Antecedents – Physical exertion Straining Sexual excitement Loss of conciousness at onset
  • 13. Focal sign – If intracerebral haematoma Hemiparesis Aphasia 3rd CN palsy – Pcom 3rd 4th 6th CN palsy-Cavernous sinus Fundus - Subhyaloid hge,Papilloedema
  • 14. Investigations • To diagnose SAH - High resolution non-contrast CT head - Lumbar puncture & CSF study - MRI brain • To identify the source - CT angiography - MR angiography - DSA
  • 15. Investigations contd.. • Others: • Complete blood count • S. electrolytes, ABG: hyponatremia • PT, APTT: coagulopathy • Cardiac enzymes, ECG
  • 16. • High resolution non-contrast CT detect SAH in almost 95% cases in first 3 days • Blood appears high density in subarachnoid space • After 5-7 days sensitivity decreases sharply • Also assesses ventricular size, infarct, hemorrhage • May predict aneurysm location based on pattern of blood • Anterior interhemispheric fissure- Acom • One sylvian fissure- Ipsilateral MCA or Pcom • Prepontine or peduncular cistern- Basilar top or SCA CT Scan
  • 18. Basilar tip aneurysm rupture Unenhanced CT brain showing blood in basal cisterns & mild hydrocephalus
  • 19. CT Scan contd.. Fisher grading for SAH on CT: • Grade 1 - No subarachnoid blood seen on CT scan • Grade 2 - Diffuse or vertical layers of SAH less than 1 mm thick • Grade 3 - Diffuse clot and/or vertical layer greater than 1 mm thick • Grade 4 - Intracerebral or intraventricular clot with diffuse or no subarachnoid blood
  • 20. Lumbar Puncture • Usually done when CT is negative but strong clinical suspicion • Opening pressure: elevated • Non-clotting bloody fluids not clearing with sequential tubes • Xanthochromia • Yellowish coloration of CSF supernatent • Almost 100% sensitive after 12 hours, 40% at 4 weeks • Spectrophotometry is more sensitive than visual inspection • False negative: Jaundice, very high CSF protein
  • 22. MRI • Not sensitive in first 24-48 hours due to less methemoglobin • Better after 4-7 days for subacute hemorrhage • FLAIR & proton density images may be as sensitive as CT in acute stage • FLAIR, DWI, GRE, proton density sequences may help diagnosis in the second week when CT are being negative
  • 23. A. GRE MRI after 10 days of SAH shows blood in left Sylvian fissure B. DSA shows a small aneurysm in left MCA bifurcation
  • 24. Angiophraphy • CTA may detect aneurysm in 97% cases • MRA is 92% sensitive, 97% specific • For decision of type of repair, DSA is indicated • Sensitivity is less for aneurysm less than 3mm size • 10-15% SAH are angio-negative (perimesencephalic SAH) • Repeat angiogram may be needed 2-3 weeks later
  • 25. Basilar tip aneurysm: before & after coiling
  • 27. Treatment Historical concept: • Strict BP control • Fluid restriction • Conservative approach & delay in specific management This approach was associated with high mortality & morbidity due to complications of hypovolemia, hypotension & rebleeding
  • 28. Treatment • Initial stabilization & monitoring • Endovascular coiling or Surgical clipping • Prevention & treatment of complications
  • 29.
  • 30. Treatment contd.. • Pt should be admitted in Neuro-ICU • Initial stabilization: Assess airway, breathing, circulation • Endotracheal intubation is indicated if the pt is in coma, depressed consciousness or unable to protect airway • Monitoring: • Cardiac monitoring • Pulse oximetry • Arterial BP monitoring • Urine output via catheter
  • 31. • The focus in the first few minutes to hours after SAH, until the patient can undergo treatment of the ruptured aneurysm, should be directed toward the prevention of rebleeding. • This life-threatening complication, with a mortality rate of 20% to 60%, has its highest rate (8%to 23%) within the first 72 hours after SAH, with the majority of rebleeding (50% to 90%) occurring within the first 6 hours
  • 32. HUNT AND HESS SCALE Grade 0: Asymptomatic Grade 1: Mild headache and mild nuchal rigidity, no neurological deficit Grade 2: Moderate to severe headache but no neurological deficit other than cranial nerve palsy Grade 3: Drowsy, confused, or mild focal deficit Grade 4: Stupor, moderate to severe hemiparesis, and early decerebrate posturing Grade 5: Deep comatose, decerebrate posturing
  • 33. WORLD FEDERATION OF NEUROLOGICAL SURGEONS (WFNS) SCALE Glasgow coma scale Motor deficit Grade 0 15 Absent Grade 1 15 Present Grade 2 13–14 Absent Grade 3 13–14 Present Grade 4 7–12 Present or absent Grade 5 3–6 Present or absent
  • 34. Blood Pressure Management • Early management is important to prevent rebleeding & to maintain cerebral perfusion pressure • Start antihypertensive agent if SBP>160 or MBP>130 mmHg • Target BP: SBP no more than 140 mmHg unless vasospasm • i.v. beta blocker labetalol, if no contra-indication, is the first choice because it has short half-life, is easily titratable & do not raise ICP • Nitroglycerine & nitroprusside raise ICP • ACE inhibitors are delayed acting
  • 35. Treatment of aneurysm • With the publication of the ISAT, the treatment of an unsecured aneurysm has shifted from surgical clipping to mostly endovascular coiling. • ISAT showed that patients in the endovascular coiling group had significantly higher odds of survival free of disability 1 year after SAH and a lower risk of epilepsy when compared to the surgical clipping group. • Even 10 years after SAH, patients who underwent endovascular coiling had better outcome.
  • 38. Endovascular & Surgical Treatment • Should be performed as early as possible in low to intermediate grade SAH (HHS or WFNS grade 1-3) • Severe grade pts may be candidate for delayed coiling or clipping • Endovascular coiling is preferred due to less complication • Follow-up vascular imaging is indicated • Retreatment should be considered by repeat coiling or clipping if there is clinically significant remnant
  • 39. Coiling vs Clipping Endovascular treatment is favored over open surgery in the following situations: • Aneurysms in the posterior circulation because of the high surgical morbidity • Patients with higher-grade SAH (i.e. Hunt and Hess/WFNS grades 4-5) • Patients who are medically unstable • Patients with symptomatic cavernous aneurysms • Patients with vasospasm • Patients in whom the aneurysm lacks a defined surgical neck • Patients with multiple aneurysms in different arterial territories if the surgical risk is high
  • 40. Coiling vs Clipping contd.. Clipping is favored in cases of: • Mass effect or large hematoma (>50 ml) associated with aneurysm • Large and giant aneurysm • MCA aneurysm • Wide-necked aneurysms - A large neck-to-dome ratio makes acute endovascular coiling of wide-necked aneurysms more difficult • Recurrent aneurysm after coil embolization
  • 41. Complications of Coiling • Aneurysm rupture • Thromboembolism with acute or delayed neurologic deficit (stroke) • Coil displacement or compaction • Nonspecific access complications such as groin hematoma or arterial dissection
  • 42. Management of neurological complications • Rebleeding • Hydrocephalus • Seizure • Delayed Cerebral Ischemia (DCI)
  • 43. Rebleeding • Most dangerous complication • Risk is 60% in first 24 hour, 20 % at 14 days • Risk factors: • Large aneurysm • Poorly controlled BP • Higher Hunt & Hess grade • Delay in coiling or clipping • Use of antiplatelet
  • 45. Rebleeding contd.. Prevention: • Bed rest in a quiet room • Analgesia, preferably with short acting agent e.g. fentanyl • Sedation, preferably with short acting agent e.g. midazolam • Stool softener • Management of BP • Early coiling or clipping • Antifibrinolytics reduce risk of rebleeding but increase risk of infarction: may be given for short term (<72 hours)
  • 46. Vasospasm & Cerebral Ischemia • Occur 7-10 days after SAH & resolves spontaneously after 21 days • Amount of blood on initial CT is a good predictor • Hypovolemia & hypotension may precipitate vasospasm • Presents with new focal neurological deficit or global symptom • Prevention: • Avoid hypotension • Maintain euvolemia • oral nimodipine for 21 days- (60 mg every 4 hours for 21 days) • Monitoring: daily bedside transcranial Doppler USG
  • 48. Vasospasm & Cerebral Ischemia contd.. Treatment of symptomatic vasospasm: • Triple H therapy: • Hypertension • Hypervolemia • Hemodilution. If bleeding site is not secured before, rebleeding may occur • Transluminal balloon angioplasty • Intra-arterial vasodilator therapy e.g. CCB, papaverine, Mg
  • 49. Acute Hydrocephalus • Usually within first 24 hours • Occurs in 20% cases • Obstructive type • Blood in ventricles in initial CT is a good predictor • Presents with sudden neurologic deterioration • CT may differentiate from rebleeding • In obtunded pt, emergency ventriculostomy is needed
  • 50. Chronic Hydrocephalus • After 10 days • 10-15% cases • Communicating type • Presents with, incontinence, ataxia, cognitive impairment • May be difficult to distinguish from vasospasm • Permanent CSF diversion (Shunt) may be needed
  • 51.
  • 52. Seizure • Occur in 26% cases • Risk factors include hematoma, infarct, MCA aneurysm • Short term prophylaxis may be considered in high risk pts • Long term prophylaxis not recommended • Phenytoin, Levetiracetam is the agent of choice • Phenytoin i.v. can achieve rapid therapeutic concentration and it does not cause alteration in consciousness • Phenobarbital produces a sedative effect, which may mask the neurologic evaluation
  • 53. Medical complications • Cardiorespiratory Dysfunction • Fever • Hyponatremia • Thromboembolism & prophylaxis • Glycemic Dysfunction
  • 54. Hyponatremia • Occur in 10-30% cases • Cerebral salt wasting occur due to excess BNP • SIADH may also occur • CSW is hypovolemic, SIADH is euvolemic • Isotonic saline prevents hypovolemia, but not hyponatremia for which hypertonic saline may be needed
  • 55. Cardiopulmonary dysfunction • Ranges from minor ECG changes to severe stress cardiomyopathy and neurogenic pulmonary edema. • The severity of SAH is an independent predictor of cardiopulmonary injury, • The cardiopulmonary injury is neurally mediated. • Cardiopulmonary complications after SAH are usually transient and resolve within several days to 2 weeks.
  • 56. • Fever - most common medical complication( up to 70% of patients) - searching for infection & antipyretic • Glycemic Dysfunction: -current recommendations are to maintain a blood glucose level between 80 mg/dL and 200 mg/dL.
  • 57. Deep vein thrombosis prophylaxis • All pt should have pneumatic compression stocking • UH can be used within 1-2 days following aneurysms treatment • IVC filter if DVT or PE occurs after clipping • Systemic anticoagulation if DVT or PE occurs after coiling..
  • 58. Reference • CONTINUUM (MINNEAP MINN) 2018;24(6, NEUROCRITICAL CARE): 1623–1657. • Harrison's Principles of Internal Medicine, Twentieth Edition. • Adams and Victor's Principles of Neurology 11th Edition